OCTO DATA MANAGER
I joined the Oncology Clinical Trials Office (OCTO) as Data Manager in March 2012. Prior to this I was a Data Manager at the Early Phase Clinical Trials Unit. Before coming to the UK I was leaving in Greece, there I was teaching statistics at Vocational Training Institutes and I was as a consultant for the statistical analysis of medical data .
I am currently working on 3 different oncology studies:
SCALOP-2- A multi- centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer.
CHARIOT- A phase I dose escalation safety study combining the ART inhibitor M6620 (Berzosertib) with chemoradiotherapy in oesophageal cancer & other solid cancers using time to event continual reassessment method.
OxPLoreD- Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception study.